Tie2: a journey from normal angiogenesis to cancer and beyond
about
Analysis of circulating hem-endothelial marker RNA levels in preterm infants.Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity.Use of adenoviral vectors to target chemotherapy to tumor vascular endothelial cells suppresses growth of breast cancer and melanomaAngiogenic cytokines are antibody targets during graft-versus-leukemia reactions.Lactate engages receptor tyrosine kinases Axl, Tie2, and vascular endothelial growth factor receptor 2 to activate phosphoinositide 3-kinase/Akt and promote angiogenesis.Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.Transcriptional targeting of tumor endothelial cells for gene therapy.A critical analysis of current in vitro and in vivo angiogenesis assays.Endothelial progenitor cells contribute to the development of ovarian carcinoma tumor blood vesselsModular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.TIE2 associates with caveolae and regulates caveolin-1 to promote their nuclear translocation.High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma.Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transportersNormalizing Tumoral Vessels to Treat Cancer: An Out-of-the-Box Strategy Involving TIE2 Pathway.Endothelial siRNA delivery in nonhuman primates using ionizable low-molecular weight polymeric nanoparticles.Targeting the Tie2-αβ integrin axis with bi-specific reagents for the inhibition of angiogenesis
P2860
Q33474572-A3CCF461-F258-4637-A92F-F38775EB10FFQ33802690-5B8087CC-766D-4A0D-864A-A26AE948CCE5Q33931576-769FDBE7-3BFC-4916-9091-823C322885B7Q35533586-4CEAF804-41FD-4917-AE11-07FFA8606DE6Q37175153-430E0684-27EC-4F96-87E8-783EAAB3090CQ37315498-7DAF2C43-3687-46AD-B14C-4911F4F9E316Q37459648-F6E1A999-A700-4934-872F-E78F9C9EE17AQ37534963-AF2CBD86-D1A8-4B22-B0E6-88354784E21BQ37720004-F64B0609-CE7B-4114-AB37-1A1EAB310C73Q38259956-A01A4458-AC16-4F3A-B07F-B15EA2F418EEQ38650902-38D9E967-F585-4B51-899E-A5117BBABAA2Q38654361-581EAA53-416B-4C3F-BCE3-77C7C6C38419Q39855649-62DA6BC3-5FBB-4F3E-92A9-25F1B2F1AF9AQ41710508-4275A855-1EF1-4B84-9308-0F6D53B08E39Q55513382-1CEA0E44-E23B-45AF-B080-E05F94A85857Q56888898-02AE7664-E7A6-4F4A-805C-D507F40D80FA
P2860
Tie2: a journey from normal angiogenesis to cancer and beyond
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Tie2: a journey from normal angiogenesis to cancer and beyond
@ast
Tie2: a journey from normal angiogenesis to cancer and beyond
@en
Tie2: a journey from normal angiogenesis to cancer and beyond
@en-gb
Tie2: a journey from normal angiogenesis to cancer and beyond
@nl
type
label
Tie2: a journey from normal angiogenesis to cancer and beyond
@ast
Tie2: a journey from normal angiogenesis to cancer and beyond
@en
Tie2: a journey from normal angiogenesis to cancer and beyond
@en-gb
Tie2: a journey from normal angiogenesis to cancer and beyond
@nl
prefLabel
Tie2: a journey from normal angiogenesis to cancer and beyond
@ast
Tie2: a journey from normal angiogenesis to cancer and beyond
@en
Tie2: a journey from normal angiogenesis to cancer and beyond
@en-gb
Tie2: a journey from normal angiogenesis to cancer and beyond
@nl
P2093
P356
P1476
Tie2: a journey from normal angiogenesis to cancer and beyond
@en
P2093
P304
P356
10.14670/HH-23.773
P407
P577
2008-06-01T00:00:00Z